Isdn

Isosorbide dinitrate, the active ingredient in Isdn, is an organic nitrate presented as an oral dosage form for oral use. It is employed to relieve chest pain caused by reduced blood flow to the heart and to improve symptoms in patients with certain cardiac conditions. It works by dilating blood vessels, thereby decreasing the heart’s workload.

GNH USA supplies Isdn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide dinitrate is used in the management of several cardiovascular conditions where reduction of myocardial oxygen demand is required.

- Angina pectoris: alleviates chest pain by reducing cardiac preload and afterload. - Heart failure: improves symptoms by decreasing ventricular filling pressures. - Myocardial infarction prophylaxis: lowers the risk of recurrent ischemic events after an acute coronary event.

Isosorbide dinitrate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache - Dizziness or light‑headedness - Flushing of the skin - Hypotension (low blood pressure) - Tachycardia (fast heart rate) - Nausea or upset stomach

Serious or Rare Side Effects: - Severe hypotension leading to syncope - Myocardial infarction or worsening ischemia - Allergic reactions such as rash or angioedema - Methemoglobinemia - Life‑threatening arrhythmias - Cardiogenic shock

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: check for excessive hypotension, especially after the first dose. - Avoid use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Assess renal or hepatic impairment: dose may need adjustment in severe dysfunction. - Educate patients on orthostatic dizziness: advise rising slowly from sitting or lying positions. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Isosorbide dinitrate can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Sildenafil, tadalafil or other PDE‑5 inhibitors: may cause severe hypotension. - Other organic nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood pressure drop. - Antihypertensive agents (e.g., ACE inhibitors, ARBs, calcium channel blockers): may potentiate blood pressure lowering.

Moderate Interactions (Monitor Closely): - Diuretics: can enhance hypotensive response. - Beta‑blockers: may mask tachycardia that signals low blood pressure. - Alcohol: may increase vasodilatory side effects such as dizziness and flushing.